Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Wolf

Showing results (201-210 of 331) with videos related to

Pageof 34
Sort By:
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
Frontiers in Aging Neuroscience|May 6, 2026
Resting-state brain activity and association with physical activityGeorgia Koromila, Martin Dyrba, Dominik Wolf, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2004
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseAnna Maria Wolf, Dominik Wolf, Holger Rumpold, et al.
Leukemia & Lymphoma|March 3, 2021
The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation studyJoaquín Martínez-López, Satu Mustjoki, Kimmo Porkka, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Tumor rejection in <i>Cblb</i><sup>-/-</sup> mice depends on IL-9 and Th9 cellsOliver Schanz, Isabelle Cornez, Sowmya Parampalli Yajnanarayana, et al.
Cell Reports|September 22, 2015
The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune SurveillanceNatascha Hermann-Kleiter, Victoria Klepsch, Stephanie Wallner, et al.
Wiener Klinische Wochenschrift|November 20, 2020
Austrian recommendations for the management of essential thrombocythemiaVeronika Buxhofer-Ausch, Sonja Heibl, Thamer Sliwa, et al.
Frontiers in Aging Neuroscience|March 18, 2021
Dorsolateral Prefrontal Functional Connectivity Predicts Working Memory Training GainsSofia Faraza, Julia Waldenmaier, Martin Dyrba, et al.
Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Pageof 34

Showing results (201-210 of 331) with videos related to

Sort By:
Pageof 34
Journal of Medicinal Chemistry|December 18, 2024
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan DerivativesAnna M Schoepf, Maximilian Gebhart, Martin Federspiel, et al.
Frontiers in Aging Neuroscience|May 6, 2026
Resting-state brain activity and association with physical activityGeorgia Koromila, Martin Dyrba, Dominik Wolf, et al.
Clinical Immunology (Orlando, Fla.)|September 24, 2004
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseAnna Maria Wolf, Dominik Wolf, Holger Rumpold, et al.
Leukemia & Lymphoma|March 3, 2021
The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation studyJoaquín Martínez-López, Satu Mustjoki, Kimmo Porkka, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Tumor rejection in <i>Cblb</i><sup>-/-</sup> mice depends on IL-9 and Th9 cellsOliver Schanz, Isabelle Cornez, Sowmya Parampalli Yajnanarayana, et al.
Cell Reports|September 22, 2015
The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune SurveillanceNatascha Hermann-Kleiter, Victoria Klepsch, Stephanie Wallner, et al.
Wiener Klinische Wochenschrift|November 20, 2020
Austrian recommendations for the management of essential thrombocythemiaVeronika Buxhofer-Ausch, Sonja Heibl, Thamer Sliwa, et al.
Frontiers in Aging Neuroscience|March 18, 2021
Dorsolateral Prefrontal Functional Connectivity Predicts Working Memory Training GainsSofia Faraza, Julia Waldenmaier, Martin Dyrba, et al.
Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Pageof 34